UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549


 
FORM 8-K
 


CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of report (Date of earliest event reported):  December 30, 2010

Health Discovery Corporation
(Exact name of registrant as specified in charter)


Georgia
333-62216
74--3002154
(State of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
 
2 East Bryan Street, Suite 601, Savannah, GA  31401
(Address of principal executive offices / Zip Code)
 
912-443-1987
(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communications pursuant to Rule 425 under the Securities Act.
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act.
 
o
Pre-commencement communications pursuant to Rule 14d—2(b) under the Exchange Act.
 
o
Pre-commencement communications pursuant to Rule 13e—4(c) under the Exchange Act.

 

 
 

 

 
 ITEM 5.02            Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 30, 2010, the Board of Directors of Health Discovery Corporation (the “Company”) unanimously approved the payment of a $100,000 discretionary performance bonus to Stephen D. Barnhill, M.D., the Chairman of the Board and Chief Executive Officer of the Company.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.




 
HEALTH DISCOVERY CORPORATION
       
Dated:  January 5, 2011
By:
/s/ Thomas L. Gallagher
 
   
President and General Counsel